KRON — Kronos Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $61.30m
- -$111.70m
- $6.29m
- 26
- 32
- 46
- 27
Annual cashflow statement for Kronos Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.1 | -88.4 | -151 | -133 | -113 |
| Depreciation | |||||
| Non-Cash Items | 0.403 | 43.2 | 32.8 | 33.8 | 26.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.276 | 6.46 | -1.62 | 6.18 | 5.88 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -15.1 | -37.9 | -118 | -90.9 | -78.6 |
| Capital Expenditures | -2.95 | -9.57 | -4.26 | -0.577 | -0.679 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -64.6 | -151 | 68 | -31.6 | 67 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -67.6 | -160 | 63.7 | -32.2 | 66.4 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 105 | 416 | 4.46 | 0.851 | 0.567 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 22.3 | 217 | -49.7 | -122 | -11.6 |